Abstract: Messenger RNA is recruited to the eukaryotic ribosome by a complex including the eukaryotic initiation factor (eIF) 4E (the cap-binding protein), the scaffold protein eIF4G and the RNA helicase eIF4A. To shut-off host-cell protein synthesis, eIF4G is cleaved during picornaviral infection by a virally encoded proteinase; the structural basis of this reaction and its stimulation by eIF4E is unclear. We have structurally and biochemically investigated the interaction of purified foot-and-mouth disease virus (FMDV) leader proteinase (Lb pro ), human rhinovirus 2 (HRV2) 2A proteinase (2A pro ) and coxsackievirus B4 (CVB4) 2A pro with purified eIF4GII, eIF4E and the eIF4GII/ eIF4E complex. Using nuclear magnetic resonance (NMR), we completed 13 C/ 15 N sequential backbone assignment of human eIF4GII residues 551-745 and examined their binding to murine eIF4E. eIF4GII 551-745 is intrinsically unstructured and remains so when bound to eIF4E. NMR and biophysical techniques for determining stoichiometry and binding constants revealed that the papain-like Lb pro only forms a stable complex with eIF4GII in the presence of eIF4E, with K D values in the low nanomolar range; Lb pro contacts both eIF4GII and eIF4E. Furthermore, the unrelated chymotrypsin-like 2A pro from HRV2 and CVB4 also build a stable complex with eIF4GII/eIF4E, but with K D values in the low micromolar range. The HRV2 enzyme also forms a stable complex with eIF4E; however, none of the proteinases tested complex stably with eIF4GII alone. Thus, these
Introduction
Successful viral replication requires rapid modulation of the infected cell's physiology. Interference with the host cell's machinery for protein synthesis is a mechanism favoured by positive strand RNA viruses to increase the efficiency of viral mRNA translation. The shut-off of host cell protein synthesis by picornaviruses, first observed in 1963 by Penman et al.,
1 is a classic example. The effect has since been observed during replication of poliovirus (PV), coxsackievirus (CV) and human rhinovirus (HRV) (members of the enterovirus genus) and foot-andmouth disease virus (FMDV, a member of the aphthovirus genus). 2, 3 The shut-off occurs one to two hours post-infection and before replication of the RNA genome takes place; thus, the reaction is efficiently carried out by proteinases translated from the RNA genome of the infecting particle. 4 Cleavage of the two isoforms of the cellular eukaryotic initiation factor (eIF) 4G, eIF4GI and eIF4GII [ Fig. 1(A) ], observed in all enteroviruses and aphthoviruses so far examined, separates the domain that binds the polyA binding protein (PABP) and eIF4E (the capbinding protein) from that binding eIF4A (an ATPdependent RNA helicase), the protein complex eIF3 that binds to the 40S ribosomal subunit and the growth factor sensitive Mnk-1 kinase. 5, 6 Consequently, the host cell fails to recruit capped mRNA to the ribosome; in contrast, viral RNA translation is initiated through the internal ribosome entry site (IRES) at the RNA's 5' end. 7 In FMDV, the shut-off of host cell translation through cleavage of eIF4G prevents synthesis of interferons and related cytokines, thus impairing host innate immunity. 8 Cleavage of eIF4G isoforms in FMDV is performed by the Leader proteinase (Lb pro ), a papainlike cysteine proteinase, with a globular domain of 155 amino acids and a C-terminal extension (CTE) of 18 amino acids. In enteroviruses, the cleavage is performed by the chymotrypsin-like 2A proteinase (2A pro ). The outcome of the cleavage of the two isoforms of eIF4G is the same; nevertheless, the cleavage sites and the mechanisms leading to the cleavage are not identical. Thus, on eIF4GI, the cleavages sites are located 7 amino acids apart whereas in eIF4GII, they are adjacent [ Fig. 1(A) ]. 9 Prior to cleavage of the eIF4G isoforms, Lb pro binds to an exosite on the eIF4G isoforms located between 30 and 50 amino acids N-terminal to the cleavage site [ Fig GST pull-down experiments using full-length eIF4GI from rabbit reticulocyte lysates (RRLs) requires the presence of eIF4E; 10, 11 furthermore, cleavage of both full-length and suitable fragments of eIF4G isoforms by both enzymes is stimulated in the presence of eIF4E in RRLs and in human 293 cells. 9, 12, 13 Indeed, with the Lb pro , cleavage of full-length eIF4GI in
RRLs could be completely abrogated by addition of eIF4E-binding protein to complex the eIF4E. 13 The stoichiometry and structural basis of the stimulation of eIF4G isoform cleavage by eIF4E are unknown. Structural information on the two proteinases as well as yeast and mammalian eIF4E is available. [14] [15] [16] [17] [18] For mammalian eIF4G, structural infor- ; nevertheless, the interaction of human eIF4E with human eIF4GI residues 557-646 has been characterised by isothermal titration calorimetry (ITC). 22 For yeast, the solution structure of residues 393-490 bound to yeast eIF4E has been determined, with residues 393-490 forming a ring around the N-terminus of eIF4E. 23 However, the yeast eIF4G is not cleaved by the HRV2 2A pro or the CVB4 2A pro24 and the sequence C-terminal to the eIF4E binding site shows low similarity to that found in mammalian eIF4G, putting into question the relevance of this structure for this region of the mammalian protein. Supporting Information Figure  S1 aligns the amino acid sequence of yeast eIF4G with those of human eIF4GI and eIF4GII (Supporting Information Fig. S1 ). The identity of the eIF4-GII 551-745 fragment to the corresponding regions of human eIF4GI and yeast eIF4GI is 48% and 20%, respectively.
To investigate the interaction of FMDV Lb pro as well as HRV2 and CVB4 2A pro with mammalian eIF4G and the eIF4G/eIF4E complex and the mechanism of stimulation of cleavage by eIF4E, we biochemically and biophysically characterised the formation of protein complexes between three picornaviral proteinases and the mammalian translation initiation factors and structurally characterised First, we wished to quantify the stimulation of picornaviral cleavage of eIF4GII 551-745 using the purified proteins; no data on the exact extent of stimulation are available. Thus, in an activity assay, cleavage of 1 mg (5 mM) of eIF4GII 551-745 was faintly visible in the presence of 1 ng sLb pro (concentration 0.125 mg/mL; 7 nM) following 90 min of incubation [ Fig. 1(B) ]. However, the presence of 1 mg (5 mM) of recombinant full-length murine eIF4E purified from supernatants of E.coli lysates, cleavage of eIF4-GII 551-745 was already detectable after 10 min and 50% cleavage was reached between 20 and 30 minutes [ Fig. 1(B) ]. N-terminal sequencing and mutational analysis both confirmed that cleavage of sLb pro on eIF4GII 551-745 was between residues G700 and S701, as determined previously. 9 To obtain cleavage of eIF4GII unspecific digestion of the eIF4GII 551-745 fragment by broad specificity proteinases, such as trypsin and elastase (Supporting Information Fig. S3 ), indicating that the stimulation of cleavage by eIF4E was a specific effect of viral enzymes.
Why is picornaviral cleavage of eIF4GII Fig. S4 ). This value is 10 fold higher than that reported for the interaction of human eIF4E with human eIF4GI (residues 557-646) and yeast eIF4E with eIF4GI (residues 393-490). 22, 23 This may be due to differences in experimental procedures or may reflect variations in the amino acid sequences of the two isoforms. N) chemical shift perturbations were observed between the spectra of eIF4GII and the eIF4GII 551-745 /eIF4E complex, indicating that the binding of eIF4E did not induce any readily observable structural changes in the conformation of eIF4GII . Instead, binding of eIF4E to eIF4-GII 551-745 markedly broadens signals of 72 residues (606-677) and attenuates, albeit to a lesser extent, the signals of residues from 678-735 (further away from the eIF4E binding site).
Global changes in the signal intensities in 15 N heteronuclear single quantum coherence (HSQC) spectroscopy spectra of eIF4GII 551-745 induced by complex formation are compared in Figures 3 and 4(A,B) . The reasons for the signal broadening in the eIF4GII 551-745 /eIF4E are diverse, including conformational exchange and dynamics as well as some increase in the molecule mass of the resulting particle. The dynamic behavior of the intrinsically disordered eIF4GII 551-745 is complex and still under investigation. Conformational dynamics and exchange between different states of eIF4GII 551-745 can occur within the free or the bound form or between the two forms as has been observed for other IDPs such as the eIF4E-binding protein 4E-BP2 that binds to eIF4E through an extended binding interface. 32 The lack of observable 15 N relaxation dispersion effects would suggest that dynamics in free eIF4GII are probably fast on an NMR time scale. In contrast, the low lM affinity of the eIF4GII 551-745 /eIF4E complex implies that conformational exchange between free and eIF4E bound eIF4GII is likely to be slow on the NMR time scale, as indicated by the complete absence of a second set of peaks for the bound form, again as was observed for 4E-BP2. 32 In summary, the direct observation of the bound eIF4GII 551-745 species is precluded by its dynamics and the conformational heterogeneity of a 'fuzzy' and extended ensemble, most likely interfacing with a large region on the surface of eIF4E. Nevertheless, we were able in the present study to use signal attenuation as a qualitative indication of the binding interaction. The average and standard deviation were calculated from three experiments. From the above NMR experiments, we conclude that human eIF4GII 551-745 remained intrinsically unstructured in complex with murine eIF4E and the resulting complex can be described as 'fuzzy' complex. This contrasts with the situation with the yeast fragment eIF4GI , for which the NMR data indicates that this region of eIF4GI forms an ordered ring around the N-terminus of yeast eIF4E. 23 In the crystal structure of eIF4E with an eIF4GII peptide 14 corresponding to residues 622-633, a short a-helix was observed. In HNCA experiments (data not shown) using eIF4E and eIF4GII , no such a-helix formation was noted for the observable residues (627-631), indicating a further difference to the yeast system. Interestingly, in our system, this region which comprises the canonical Y(X)4LU binding motif displays some consistent, but small secondary shifts, indicative of transient a-helix formation. SSP 30 software reveals a small (ca. 0.18) helical propensity for this region in an otherwise unstructured protein; this is consistent with a nascent a-helix.
In the eIF4GII 551-745 /eIF4E/sLb pro C51A complex, signals between residues 606-735 were further reduced in intensity; in addition, signals from 735 onwards were attenuated (Fig. 4 , compare A and B). [ Fig. 5(B Table I ), but not with eIF4GII [ Fig. 5(C) ]. Second, the affinity for the interaction of eIF4GII 551-745 /eIF4E with 2A pro C106S was approximately 100 times lower than that determined for the sLb pro C51A (Table I ). These differences are reflected in the slower rates in vitro [ Fig. 1 The inactive CVB4 2A pro C110A could also form a complex with the eIF4GII 551-745 /eIF4E complex [ Fig. 5(D) ]. However, in contrast to the HRV2 enzyme, the CVB4 2A pro behaves as a monomer (Table II) and does not form a stable complex with either eIF4E or eIF4GII 551-745 . [ Fig. 5(E,F) With just eIF4E added, the line broadening is more pronounced; thus, intensities across the entire protein, including the C-terminal residues 183-191 are attenuated, indicating an interaction with low specificity, although heterogeneity and exchange dynamics may also contribute to this effect. In the eIF4GII 551-745 /eIF4E/sLb pro C51A complex, essentially all amide signals of sLb pro C51A were lost, except for the very C-terminal residues 194 and 195. As the effect is widespread across the whole surface of sLb pro C51A, it probably originates from the increase in particle size as well as including a contribution from exchange dynamics.
These results provide evidence for weak, low-to intermediate affinity interactions (too low to be accessible by ITC) between sLb pro C51A and eIF4E
that include its C-terminal residues with K D values in the mid to high micromolar range (estimated by NMR, as the complex appears to still be in 'fast exchange' on the NMR timescale); these interactions help form and stabilise the triangular eIF4GII 551-745 /eIF4E/sLb pro C51A complex, that is one with pairwise contacts between all three pairs of proteins as defined by Popov.
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C-terminal residues of sLb pro interact with eIF4E
Overall, the above NMR data indicate differing structural contexts and environments for eIF4GII 551-745 residues 551-605 and 606-745 as well as the close proximity and direct contacts of the C-terminal sLb pro residues to the eIF4E in the eIF4GII 551-745 /eIF4E/ sLb pro C51A complex. To investigate these insights further, we used paramagnetic relaxation enhancement (PRE) to sensitively probe local compaction by intramolecular PREs and transient tertiary contacts by intermolecular PREs. A paramagnetic spin-label (S-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl methanesulfonothioate, MTSL), reaching out up to approximately 20 Å , was first attached to residue C638 of eIF4GII 551-745 and the NMR spectra of this protein alone were recorded. Most signals from residues 606-715 (which is also the region of interaction with eIF4E and sLb pro ) were lost, with those from 715-745 being affected to a lesser degree [Supporting Information Fig. S7(A) ]. Thus, the residues whose NMR relaxation properties are affected by eIF4E or sLb pro are indeed located in a fairly compact globular core of approximately 20 Å which is still partially unstructured and located in an otherwise even more unstructured protein. The spin-label was then attached to residue C133 of sLb pro C51A/C125S/ C153S and the NMR spectra of eIF4GII were measured in the presence of the spin-labelled sLb pro C51A/C125S/C153S [ Fig. S7(B 16 and showed that it could be cleaved by sLb pro [ Fig. 7(B) , upper panel]. To control that the eIF4GI construct bearing residues 619-678 of the eIF4GI sequence could serve as a substrate, we incubated it with Lb pro and showed that it could be cleaved to the same extent as the 599-678 substrate [ Fig. 7(C,D) , upper panels]. In all experiments, the synthesis of active Lb pro and sLb pro was confirmed by endogenous eIF4GI cleavage (Fig. 7 , lower panels).
Discussion
The ability of enteroviruses and aphthoviruses to replicate successfully depends on the ability of the virus to shut down the synthesis of host proteins. FMDV lacking Lb pro fail to spread in the infected are indicated. To observe cleavage on endogenous eIF4GI in the RRLs, 10 mL aliquots were analysed on 6% SDS gels followed by Western blotting using serum to detect the N-terminal part of the eIF4GI protein (lower pictures). Uncleaved eIF4GI and cleavage products (CP N ) are indicated. Negative controls without any RNA (2sub, 2prot) or comprising only RNA of the substrate protein (1sub, 2prot) are shown at the right of each gel. Protein standards are shown on the left.
animal 8 whereas enteroviruses with mutations in 2A pro have small plaque phenotypes in cell culture. 39, 40 It has long been recognised that, although the host cell shut-off achieved through the cleavage by Lb pro and 2A pro is the same, the variations in proteinase structure, locations of the cleavage sites and the times of onset of cleavage 3, [41] [42] [43] [44] imply that the interactions with the eIF4GII/eIF4E complex differ considerably. Several observations documented that the eIF4-GII 551-745 fragment analysed here behaved as the full-length eIF4G isoforms. First, complex formation between eIF4GII and eIF4E was measured by four techniques (SEC, SEC-MALLS, ITC (K D 40 nM) and NMR); mutation of the binding site for eIF4E on eIF4GII 551-745 eliminated complex formation. The observed K D of 40 nM compares well with those (around 4 nM) obtained for similar, but shorter, fragments of yeast and human eIF4GI. 22, 23 These differences may reflect amino acid differences between the two isoforms. Second, conditions were found in which cleavage of eIF4GII 551-745 by sLb pro were observed only in the presence of eIF4E, as previously observed. 13 Third, a stimulation of eIF4GII 551-745 by eIF4E was observed by both sLb pro and HRV2 2A pro ; the results shown here extend this observation to the CVB4 2A pro .
The major hurdle to the study of the nature of the complexes formed by the proteinases with the initiation factors was the assignment of the NMR signals of the human eIF4GII 551-745 . This was achieved despite the intrinsically unstructed nature of the protein. In contrast to the yeast eIF4GI , 23 human 4GII 551-745 remains intrinsically unstructured when bound to eIF4E. Indeed, neither discrete conformational changes nor a defined tertiary structure were observed on binding of murine eIF4E to the human eIF4GII . Nevertheless, the NMR data for all complexes measured are consistent with the notion that eIF4G and eIF4E form a tight complex in which eIF4E contacts between eIF4GII residues 606 and 678. Whatever the nature of the interactions, this system should prove useful in screening for compounds that interrupt this interaction, a central control point in mammalian protein synthesis. Given the lack of defined structure observed in eIF4GII 551-745 in the presence or absence of eIF4E, it is of interest to note that a similar phenomenon was previously observed in the binding of both human 4E-BP1 and 4E-BP2 to eIF4E. 32, 45 Both 4E-BP1 and 4E-BP2 are IDPs that remain unstructured when bound to eIF4E. 32, 45, 46 The binding of the 4E-BP to eIF4E represents an important control point as it prevents eIF4G isoforms from binding to eIF4E or even displaces bound eIF4G from eIF4E. 47 Studies of the interaction between eIF4E and 4E-BP have revealed that both human 4E-BP2 and 4E-BP from D. melanogaster bind to two sites (i.e., in a bipartite manner) on eIF4E 32, 47 ; for the D. melanogaster 4E-BP, one site is that at which the eIF4G isoforms bind whereas the other is on the lateral face comprising the C-terminus of helix a1 and loop 2. 47 It will be of interest to see whether the picornaviral proteinases also use the lateral face for their eIF4E interactions or a different part of the protein. C110A interact with each other, forming heterotrimeric complexes that are also termed triangular complexes. 38, 48 The triangular protein-protein interactions involved in sLb pro host cell shut-off are summarised in a model (Fig. 8) . Residues 606-705 of eIF4GII 551-745 are shown as a relatively compact, preformed domain to which eIF4E binds. In the absence of structural evidence on the parts of murine eIF4E that interact with eIF4GII, we have drawn the model with eIF4GII contacting the N-terminus of eIF4E as in the yeast system. 23 Triangular ternary complex formation is stabilised by the interaction of the globular site. Drawings were created in PyMol. 55 PDB identifiers:
1QOL, Lb pro C51A; 1EJH, eIF4E.
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sLb pro domain with its binding site on eIF4GII and by interactions of residues C133, Q185 and E186 of the C-terminus (residues marked with side-chains) with eIF4E. Further support for the importance of this reaction was provided by the experiment in which cleavage by sLb pro at the eIF4GI cleavage site could be made dependent on the presence of the eIF4E binding site on eIF4GI (Fig. 7) . Furthermore, the model explains why the presence of eIF4E can drive the processivity of eIF4G isoform cleavage as documented for Lb pro by Ohlmann et al. 13 in RRLs. Further evidence for the importance of eIF4E for the processivity is that, in actively translating ribosomes in RRLs, eIF4GI is efficiently cleaved during the synthesis of both L pro (50% cleavage in 4 min.) and HRV2
2A pro (50% cleavage in 15 min.). 49 Rau et al. 50 showed that 80% of eIF4GI is present in on the ribosome under such conditions and bound to eIF4E. This suggests that that cleavage of the eIF4G isoforms begins on the ribosome during synthesis of proteins from the RNA of the genome of the infecting particle, thus explaining the efficient cleavage of the isoforms in vivo. Indeed, cleavage of the eIF4G isoforms has been observed during PV under conditions that prevented the replication of viral RNA. 4 The HRV2 2A pro C106S also formed a triangular heterotrimeric complex with eIF4GII and eIF4E. However, the affinity of this 2A pro to the eIF4E/eIF4-GII complex was lower than that of sLb pro . Furthermore, the stoichiometry of the HRV2 2A pro C106S
complex remained unclear as SLS measurements indicated an apparent molecular mass of 104-109 kDa (Table II) . This corresponds neither to a 1:1:1 complex nor to any simple multiples of the components. Given this uncertain stoichiometry and the ill-defined nature of the binding site for HRV2 2A pro , 11 we cannot yet provide a model for HRV2 2A pro analogous to that for sLb pro shown in Figure 8 .
A further interesting observation was the formation of a stable complex between HRV2 2A pro C106S
and eIF4E, as evidenced by SEC, SLS and ITC measurements. This interaction helps to explain why previous attempts to exactly define the binding site of HRV2 2A pro on eIF4GI (600-674) or eIF4GII
[613-685, Fig. 1(A) ] met with little success. 11 In these experiments, performed in the presence of eIF4E, binding of HRV2 2A pro to eIF4G was lost upon deletion of the eIF4E binding site. Thus, it would appear that eIF4E is acting as a bridge to anchor the HRV2 2A pro to the eIF4G isoforms, indicating a fundamental difference to the model for sLb pro shown in Figure 8 .
The apparent molecular mass determined by SLS on eIF4E/2A pro C106S complexes formed overnight was 38-40 kDa (Table II) nevertheless, they share an amino acid identity of about only 40% (Supporting Information Fig. S8) , with the majority of the identity in the C-terminal domain. One might therefore predict that the CVB4 and HRV2 2A pro behave differently toward eIF4E and the eIF4GII/eIF4E complex itself. These mechanistic differences may also explain why HRV2 cleaves both isoforms at the same rate in infected HeLa cells whereas in HRV14 and PV (both of which are more closely related to CVB4 than HRV2) infected HeLa cells, the eIF4GI isoforms are cleaved more rapidly than the eIF4GII isoforms. 35, 41, 42 Investigation of the importance of eIF4E interactions on the cleavage of full-length eIF4G isoforms during infection awaits the development of cell lines over-expressing recombinant eIF4G that can be infected by picornaviruses. In summary, the data presented here show that FMDV sLb pro , HRV2 2A pro and CVB4 2A pro have each evolved different interactions to interact with the eIF4GII 551-745 /eIF4E complex, even though the viruses are all from the same family and that two of the proteinases share the same reduced chymotrypsin-fold. 
Materials and Methods
Materials
Protein expression and purification
Fragments of eIF4GII (all having a C-terminal HisTag) were expressed in BL21(DE3) grown in LB medium for biochemical analysis or minimal medium (M9) for NMR studies containing N-ammonium chloride as sole nitrogen source. Briefly, transformed bacteria were grown in 100 mL M9 medium overnight. 2 L expression cultures were then inoculated with the overnight culture and protein expression was induced at an OD 600 between 0.5 and 0.6 for 5-8 h at 378C. Following sonication, the sample was loaded on a 5 mL HisTrap HP (GE Healthcare), equilibrated with 50 mM Tris/HCl, 50 mM NaCl and 20 mM imidazole, washed with five column volumes and eluted with increasing imidazole concentration (500 mM). Pooled fractions were dialyzed into assay buffer (20 mM Hepes/KOH pH 7.4, 150 mM KCl, 1 mM EDTA and 5 mM DTT). For preparative SEC, a HiLoad 26/60 Superdex 75 pg column was used (GE Healthcare), equilibrated with assay buffer. The samples were concentrated to about 0.5-1 mM using Amicon Ultra Centrifugal Devices with a 10 kDa cut-off (Millipore). For expression of unlabelled eIF4-GII, expression was in LB medium and was terminated after 5 h at 378C.
Expression of sLb pro C51A (FMDV residues 29-195) was described previously. 28 PCR mutagenesis was used to restore the active cysteine residue C51. The expression and purification protocol of active sLb pro and mutants thereof was as described, 27 with the exception that plasmids were transformed in BL21(DE3)plysE and that assay buffer was used in the last step of purification. Expression and purification of active HRV2 2A pro , HRV2 2A pro C106S as well as active CVB4 2A pro and CVB4 2A pro C110A VP1 8 were performed as described previously 33, 34 with the exception that assay buffer was used in the final SEC purification step . Recombinant murine eIF4E (N-terminal HisTag) was purified from strain T7 Express (New England Biolabs). Briefly, cells from 4 L were resuspended in 40 mL 50 mM Tris/HCl pH 8, 50 mM NaCl, 1 mM EDTA and 5% glycerol, lysed by sonication and centrifuged at 18,000 rpm for 30 min at 48C. The supernatant was then loaded onto a 5 mL HisTrap, equilibrated with 50 mM Tris/HCl, 50m M NaCl and 20 mM imidazole, washed with five column volumes and eluted with increasing imidazole concentration (500 mM). Pooled fractions were loaded onto a MonoQ HR 10/100 (GE Healthcare) column, equilibrated with buffer containing 50 mM Tris/HCl pH 8.0, 50 mM NaCl, 1 mM EDTA, 5 mM DTT and 5% glycerol, washed with five column volumes and eluted with rising NaCl concentrations (1M). Pooled fractions were dialyzed into assay buffer, followed by SEC using a HiLoadV R 26/60 SuperdexV R 75 pg (GE Healthcare).
In vitro cleavage assays
Cleavage assays were performed using purified recombinant eIF4GII The nitroxide spin-label MTSL was introduced by adding two to three times excess of MTSL to the protein, which was prior separated from DTT by a PD-10 desalting column (GE Healthcare). After incubation for 2-3 h, the protein was concentrated to 500 mL. Intramolecular paramagnetic relaxation enhancements (PREs) by nitroxide spin-label MTSL in single-cysteine C638.MTSL 15 N eIF4GII 551-745 or intermolecular PREs caused by unlabelled C133.MTSL sLb pro C51A/C125S/C153S were measured as intensity ratios of cross-peaks in 2D 15 N HSQC NMR spectra between oxidized and reduced forms. DTT was used to reduce the paramagnetic spin label. Individual cross-peak intensities were normalized using the most intense peaks in each data set.
Limited proteolysis
20 mg of eIF4GII was subjected in the presence or absence of 20 mg eIF4E to limited proteolysis in assay buffer at 378C by the addition of a-chymotrypsin, trypsin, elastase, papain, subtilisin or endoproteinase Glu-C to final concentrations of 50, 5, and 0.5 mg/mL. The reaction was stopped after 60 minutes by adding 53 SDS sample buffer and immediately heated at 958C for 5 min. The samples were analysed on 17.5% polyacrylamide SDS-PAGE gels.
Analytical size-exclusion chromatography
Size-exclusion chromatography was performed with a HiLoadV R 16/60 SuperdexV R 200 pg (GE Healthcare) column, equilibrated with a assay buffer. 0.5 mg of pure protein or complexed proteins (10 minutes at 48C under gentle mixing) were injected together with 1 mg of aprotinin (6.5 kDa) using a 2 mL loop and eluted with 1 mL/min flow rate. Protein elution was monitored by following the absorption at 280 nm (mAU).
Static light scattering
For assessing the molecular weight and oligomeric state of eIF4GII 551-745 , eIF4E, sLb pro C51A and 2A pro C106S, a Superdex 200 10/300 column was equilibrated with assay buffer. The miniDAWN Trista light scattering instrument (Wyatt Technology, Santa Barbara, CA) was connected and 100 mg sample was injected on the gel-filtration column. Data analysis was performed using the manufacturer's software ASTRA.
Studying protein-protein interactions using isothermal titration calorimetry (ITC)
ITC experiments were performed on a MicroCal ITC microcalorimeter. Proteins were dialyzed before the measurement in a buffer containing 20 mM Hepes/ KOH pH 7.4, 150 mM KCl and 1 mM EDTA filtered through a 0.22 mm filter. Following thermal equilibration at 258C, an initial delay of 60 seconds and a single 0.5 mL titrant injection, 20 serial injections of 2 mL of the titrant was added at an interval of 180 seconds into the stirred sample cell (200 mL) at a stirring rate of 750 rpm at 258C. The protein concentration in the cell was about 103 lower than protein titrant. Data analysis was performed using the Origin software package MicroCal.
In vitro transcription and translation
In vitro transcription reactions were performed as described. 16, 54 In vitro translation reactions were performed as described in 16, 27 with an RNA concentration of 14ng/mL.
